Sensorion SA (ALSEN)

Profile

https://www.sensorion.com

Sensorion SA is a clinical-stage biotechnology company focused on developing therapies for inner ear disorders and hearing loss. Sensorion SA’s current portfolio centers on drug candidates and gene therapy programs designed to restore, treat, and prevent conditions such as sudden sensorineural hearing loss, cochlear damage, and hearing loss linked to specific genetic mutations. Its pipeline includes small-molecule and gene-therapy approaches that address unmet needs in otology, with research and development spanning preclinical and clinical stages. The company operates in the healthcare and biotechnology segments, where it contributes specialized therapeutic solutions for auditory diseases and related inner-ear conditions. Headquartered in Montpellier, France, Sensorion SA is positioned as a dedicated developer of targeted treatments for hearing preservation and restoration.